Downregulation of CDKN2A and suppression of cyclin D1 gene expressions in malignant gliomas

Journal of Experimental and Clinical Cancer Research

Volumn 30, Issue 1, 2011, Pages

  Liu, Weidong ^a   Lv, Guohua ^a   Li, Yawei ^a   Li, Lei ^a   Wang, Bing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RETINOBLASTOMA PROTEIN; CCND1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ADULT; ANAPLASTIC OLIGODENDROGLIOMA; ARTICLE; ASTROCYTOMA; CARCINOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; BRAIN TUMOR; CELL PROLIFERATION; CLONOGENIC ASSAY; DRUG ANTAGONISM; ENZYME IMMUNOASSAY; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; FEMALE; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; RNA, SMALL INTERFERING;

EID: 80051578712     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-30-76     Document Type: Article

References (22)

1. Epidemiology and etiology of gliomas. Ohgaki H, Kleihues P, Acta Neuropathol 2005 109 93 108 10.1007/s00401-005-0991-y 15685439 (Pubitemid 40287792)
2. Molecular pathogenesis of malignant gliomas. Rasheed BK, Wiltshire RN, Bigner SH, Bigner DD, Curr Opin Oncol 1999 11 162 167 10.1097/00001622- 199905000-00004 10328589 (Pubitemid 29229607)
3. Specific chromosomal abnormalities in malignant human gliomas. Bigner SH, Mark J, Burger PC, Mahaley MS Jr, Bullard DE, Muhlbaier LH, Bigner DD, Cancer Res 1988 48 405 411 3335011 (Pubitemid 18045778)
4. Specific chromosomal abnormalities characterize four established cell lines derived from malignant human gliomas. Bigner SH, Friedman HS, Biegel JA, Wikstrand CJ, Mark J, Gebhardt R, Eng LF, Bigner DD, Acta Neuropathol 1986 72 86 97 10.1007/BF00687952 2881426 (Pubitemid 17232773)
5. Relationship between gene amplification and chromosomal deviations in malignant human gliomas. Bigner SH, Wong AJ, Mark J, Muhlbaier LH, Kinzler KW, Vogelstein B, Bigner DD, Cancer Genet Cytogenet 1987 29 165 170 10.1016/0165-4608(87)90045-8 3478127 (Pubitemid 17159870)
6. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008 455 1061 1068 10.1038/nature07385 18772890
7. Familiality in brain tumors. Blumenthal DT, Cannon-Albright LA, Neurology 2008 71 1015 1020 10.1212/01.wnl.0000326597.60605.27 18809838
8. IDH1 and IDH2 mutations in gliomas. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, et al. N Engl J Med 2009 360 765 773 10.1056/NEJMoa0808710 19228619
9. Role of the p16 tumor suppressor gene in cancer. Liggett WH Jr, Sidransky D, J Clin Oncol 1998 16 1197 1206 9508208 (Pubitemid 28108758)
10. Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. Sekine C, Sugihara T, Miyake S, Hirai H, Yoshida M, Miyasaka N, Kohsaka H, J Immunol 2008 180 1954 1961 18209094
11. Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat. Ruef J, Meshel AS, Hu Z, Horaist C, Ballinger CA, Thompson LJ, Subbarao VD, Dumont JA, Patterson C, Circulation 1999 100 659 665 10441105 (Pubitemid 29379757)
12. Genome-wide association study identifies five susceptibility loci for glioma. Shete S, Hosking FJ, Robertson LB, Dobbins SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre JY, et al. Nat Genet 2009 41 899 904 10.1038/ng.407 19578367
13. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Moulton T, Samara G, Chung WY, Yuan L, Desai R, Sisti M, Bruce J, Tycko B, Am J Pathol 1995 146 613 619 7887443
14. Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme. Kraus JA, Glesmann N, Beck M, Krex D, Klockgether T, Schackert G, Schlegel U, J Neurooncol 2000 48 89 94 10.1023/A:1006402614838 11083071
15. Frequent homozygous deletion of p16/CDKN2A gene in malignant gliomas of Iranian patients. Zadeh MD, Amini R, Firoozray M, Derakhshandeh-Peykar P, Pak J Biol Sci 2007 10 4246 4250 19086579 (Pubitemid 350158588)
16. Functional evidence for a role of combined CDKN2A (p16-p14(ARF))/CDKN2B (p15) gene inactivation in malignant gliomas. Simon M, Koster G, Menon AG, Schramm J, Acta Neuropathol 1999 98 444 452 10.1007/s004010051107 10541865 (Pubitemid 29476161)
17. An integrated genomic analysis of human glioblastoma multiforme. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. Science 2008 321 1807 1812 10.1126/science.1164382 18772396
18. Molecular genetic analysis of giant cell glioblastomas. Meyer-Puttlitz B, Hayashi Y, Waha A, Rollbrocker B, Bostrom J, Wiestler OD, Louis DN, Reifenberger G, von Deimling A, Am J Pathol 1997 151 853 857 9284834 (Pubitemid 27385617)
19. Lack of p16INK4 or retinoblastoma protein (pRb), or amplification- associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. He J, Olson JJ, James CD, Cancer Res 1995 55 4833 4836 7585516
20. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. Beasley MB, Lantuejoul S, Abbondanzo S, Chu WS, Hasleton PS, Travis WD, Brambilla E, Hum Pathol 2003 34 136 142 10.1053/hupa.2003.8 12612881 (Pubitemid 36258804)
21. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy. Hwang CF, Cho CL, Huang CC, Wang JS, Shih YL, Su CY, Chang HW, Ann Oncol 2002 13 1246 1251 10.1093/annonc/mdf215 12181248 (Pubitemid 34960133)
22. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution. Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, Wang T, Shackleford GM, Cardiff RD, Schmidt EV, Cancer Res 2001 61 8811 8819 11751403 (Pubitemid 34013895)